Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-26

Clinical Trial Update: Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effect of folic acid in patients with Parkinson's disease treated with levodopa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • folic acid (folic acid)
  • levodopa (levodopa)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN